For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.
Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents
Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.
Support
This activity is supported by an independent educational grant from AstraZeneca LP.
Disclosures
Shmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.
Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.
Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AstraZeneca and Karius, Inc.
Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).
Speaker for International AIDS Society and MDOutlook.
Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.
Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.
Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
View all episodes
By PVI, PeerView Institute for Medical Education
3.5
2727 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.
Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents
Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.
Support
This activity is supported by an independent educational grant from AstraZeneca LP.
Disclosures
Shmuel Shoham, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Adagio Therapeutics, Inc.; Adamis Pharmaceuticals Corporation; Immunome; Karius, Inc.; Pfizer; and SCYNEXIS, Inc.
Grant/Research Support from Ansun Biopharma; Cidara Therapeutics, Inc.; F2G; Octapharma USA, Inc.; and Zeteo Biomedical LLC.
Ghady Haidar, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AstraZeneca and Karius, Inc.
Grant/Research Support from Allovir; AstraZeneca; Karius, Inc.; and National Institutes of Health (NIH).
Speaker for International AIDS Society and MDOutlook.
Carol Ann Huff, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Janssen Pharmaceuticals, Inc. and Sanofi.
Haleh Simi has no financial interests/relationships or affiliations in relation to this activity.
Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
5 Listeners
3 Listeners
4 Listeners
10 Listeners
5 Listeners
10 Listeners
3 Listeners
2 Listeners
4 Listeners
2 Listeners
3 Listeners
27,104 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
2 Listeners
107 Listeners
21,898 Listeners
11 Listeners
2 Listeners
497 Listeners
688 Listeners
3,323 Listeners
110,635 Listeners
14 Listeners
23,974 Listeners
366,915 Listeners
10,136 Listeners
2,170 Listeners